Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-13 4:15 pm Sale | 2026-09-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Affinity Asset Advisors, LLC | 1,573,517 6.500% | -500,000![]() (-24.11%) | Filing History |
| 2026-11-12 09:06 am Purchase | 2026-09-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Adage Capital Management, L.P. | 2,013,106 8.870% | 476,370![]() (+31.00%) | Filing History |
| 2026-11-09 1:45 pm Sale | 2026-09-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | THE GOLDMAN SACHS GROUP, INC. GS | 203,129 0.900% | -1,226,069![]() (-85.79%) | Filing History |
| 2026-10-28 5:34 pm Sale | 2026-09-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Integrated Core Strategies (US) LLC | 42,888 0.200% | -1,254,409![]() (-96.69%) | Filing History |
| 2026-10-08 10:26 am Sale | 2026-10-02 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | ACORN BIOVENTURES, L.P. | 1,021,668 4.500% | -262,553![]() (-20.44%) | Filing History |
| 2026-09-25 2:18 pm Unchanged | 2026-09-22 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | ACORN BIOVENTURES, L.P. | 1,284,221 5.700% | 0 (Unchanged) | Filing History |
| 2026-09-25 10:56 am Sale | 2026-09-22 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | ACORN BIOVENTURES, L.P. | 1,284,221 5.700% | -233,892![]() (-15.41%) | Filing History |
| 2026-09-04 5:35 pm Purchase | 2026-08-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Integrated Core Strategies (US) LLC | 1,297,297 5.700% | 785,726![]() (+153.59%) | Filing History |
| 2026-08-14 4:44 pm Purchase | 2026-06-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | RA Capital Management, L.P. | 2,302,504 9.900% | 223,591![]() (+10.76%) | Filing History |
| 2026-08-14 4:14 pm Sale | 2026-06-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Commodore Capital LP | 0 0.000% | -1,950,000![]() (Position Closed) | Filing History |
| 2026-08-12 12:04 pm Sale | 2026-06-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Adage Capital Management, L.P. | 1,536,736 6.780% | -285,000![]() (-15.64%) | Filing History |
| 2026-08-11 8:53 pm Purchase | 2026-06-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | THE GOLDMAN SACHS GROUP, INC. GS | 1,429,198 6.300% | 437,834![]() (+44.16%) | Filing History |
| 2026-07-28 4:44 pm Purchase | 2026-06-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | BlackRock Inc. BLK | 1,266,084 5.600% | 988,098![]() (+355.45%) | Filing History |
| 2026-06-05 11:43 am Sale | 2026-05-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | T. Rowe Price Investment Management, Inc. | 1,539,147 6.600% | -705,274![]() (-31.42%) | Filing History |
| 2026-05-15 4:59 pm Unchanged | 2026-03-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Ikarian Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-05-15 2:58 pm Purchase | 2026-05-13 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | ACORN BIOVENTURES, L.P. | 1,518,113 6.700% | 1,518,113![]() (New Position) | Filing History |
| 2026-05-14 4:05 pm Purchase | 2026-03-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Affinity Asset Advisors, LLC | 2,073,517 8.600% | 360,425![]() (+21.04%) | Filing History |
| 2026-05-13 09:23 am Purchase | 2026-03-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Adage Capital Management, L.P. | 1,821,736 8.080% | 1,385,000![]() (+317.13%) | Filing History |
| 2026-05-12 3:57 pm Purchase | 2026-03-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | THE GOLDMAN SACHS GROUP, INC. GS | 991,364 5.100% | 991,364![]() (New Position) | Filing History |
| 2026-05-11 4:23 pm Sale | 2026-03-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Opaleye Management Inc. | 619,089 2.670% | -949,913![]() (-60.54%) | Filing History |

